What Commission Implementing Regulation (EU) 2026/372 of 20 February 2026 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-decanol, 1-naphthylacetamide, 1-naphthylacetic acid, 6-benzyladenine, aluminium sulfate, boscalid, dodine, esfenvalerate, eugenol, fenpyroximate, fluazifop-P, fluazinam, fluometuron, fluopyram, flutolanil, geraniol, malathion, penoxsulam, pinoxaden, prohexadione, proquinazid, prosulfuron, pyrethrins, pyridaben, pyrimethanil, sintofen, spiroxamine, sulphur and thymol requires
Commission Implementing Regulation (EU) 2026/372, adopted on 20 February 2026 and published in the Official Journal of the European Union (L series, 23.2.2026), amends Implementing Regulation (EU) No 540/2011 to extend the approval periods of 29 active substances used in plant protection products. The Regulation is adopted pursuant to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market, and in particular Article 17, first paragraph, thereof. The Regulation applies to all EU Member States and is binding in its entirety and directly applicable in all Member States. The core obligation is the amendment of the Annex to Implementing Regulation (EU) No 540/2011 to replace the expiration dates in the sixth column (expiration of approval) for each of the 29 named active substances across Parts A, B, and E of that Annex. Extensions are granted because it is likely that no decision on the renewal of the approval can be taken before the expiry of the respective approval periods, between 15 April and 31 July 2026, and the Commission considers that the reasons for the delays in each of these renewal procedures are beyond the control of the respective applicants. Extension durations vary by substance: 12 months for flutolanil, penoxsulam, pyrimethanil and sulphur; 19 months and 15 days for fenpyroximate, fluazinam and proquinazid; 22 months and 15 days for pyrethrins; 23 months and 15 days for 1-decanol, boscalid, dodine, eugenol, fluopyram, geraniol, malathion, prohexadione and thymol; and 42 months for 1-naphthylacetamide, 1-naphthylacetic acid, 6-benzyladenine, aluminium sulfate, esfenvalerate, fluazifop-P, fluometuron, pinoxaden, prosulfuron, pyridaben, sintofen and spiroxamine.
Pillar: Legal & IP Sovereignty · Authority: European Commission · Version: 1.0.0 · Last updated:
Primary source: https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:32026R0372
SHA-256 integrity: 047167d06543bb2a8690a23dd90787d1f37958cf633954fab1d3c8fbb47ae89e
Primary Citations — 12 traced to source
- Article 1: 'The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.'
- Article 2: 'This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union. This Regulation shall be binding in its entirety and directly applicable in all Member States.'
+ 10 more citations (full bibliography, deterministic workflow, actionable schema and crosswalks) included in the vault unlock — $0.01 via Skyfire / L402 / Direct Base USDC.
Access
- Discovery (free): /api/v1/nodes/eu-celex-32026r0372.json — 6-field metadata
- Vault (full node): /api/v1/vault/nodes/eu-celex-32026r0372.json — full 13-key payload, $0.01 USDC (L402/Skyfire/Direct Base)
- Canonical URL: https://bidda.com/intelligence/eu-celex-32026r0372
- Back to registry: Browse all 10,099 compliance nodes